These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Another brick in the wall. Paschoal ME; Lapa e Silva JR Sao Paulo Med J; 2002 Mar; 120(2):35. PubMed ID: 11994769 [No Abstract] [Full Text] [Related]
48. Nicotinic acetylcholine receptors mediate lung cancer growth. Improgo MR; Soll LG; Tapper AR; Gardner PD Front Physiol; 2013; 4():251. PubMed ID: 24062692 [TBL] [Abstract][Full Text] [Related]
49. Acetylcholine receptor pathway in lung cancer: New twists to an old story. Niu XM; Lu S World J Clin Oncol; 2014 Oct; 5(4):667-76. PubMed ID: 25302169 [TBL] [Abstract][Full Text] [Related]
50. New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer. Chikova A; Bernard HU; Shchepotin IB; Grando SA Life Sci; 2012 Nov; 91(21-22):1103-8. PubMed ID: 22280835 [TBL] [Abstract][Full Text] [Related]
52. α7 nicotinic acetylcholine receptors in lung cancer. Wang S; Hu Y Oncol Lett; 2018 Aug; 16(2):1375-1382. PubMed ID: 30008813 [TBL] [Abstract][Full Text] [Related]
53. Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma. Pal K; Hussain T; Xie H; Li S; Yang P; Mansfield A; Lou Y; Chowdhury S; Mukhopadhyay D Front Oncol; 2022; 12():959500. PubMed ID: 36072788 [TBL] [Abstract][Full Text] [Related]
54. Insights into the Mechanisms of Action of Proanthocyanidins and Anthocyanins in the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer. Alsharairi NA Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887251 [TBL] [Abstract][Full Text] [Related]
55. Acetylcholine signaling system in progression of lung cancers. Friedman JR; Richbart SD; Merritt JC; Brown KC; Nolan NA; Akers AT; Lau JK; Robateau ZR; Miles SL; Dasgupta P Pharmacol Ther; 2019 Feb; 194():222-254. PubMed ID: 30291908 [TBL] [Abstract][Full Text] [Related]
56. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line. Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253 [TBL] [Abstract][Full Text] [Related]
57. Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer. Zienolddiny S; Skaug V Lung Cancer (Auckl); 2012; 3():1-14. PubMed ID: 28210120 [TBL] [Abstract][Full Text] [Related]
58. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers. Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306 [TBL] [Abstract][Full Text] [Related]
59. Curcumin protects against nicotine-induced stress during protein malnutrition in female rat through immunomodulation with cellular amelioration. Maiti M; Chattopadhyay K; Verma M; Chattopadhyay B Mol Biol Rep; 2015 Dec; 42(12):1623-37. PubMed ID: 26559197 [TBL] [Abstract][Full Text] [Related]